Furthermore, metformin, a mainstay first-line antidiabetic, prevented hyperinsulinemia and slowed tumor development including progression to advanced PanINs and PDAC in a faithful oncogenic Kras-driven autochthonous model (PK) fed a high-fat, high-calorie diet (Chang et al, 2018). The gene discussed is KRAS; the disease is hyperinsulinism.